Head of Finance, Europe

Join us in advancing the first ophthalmic formulation of bevacizumab, now in regulatory review. Be part of a mission that’s redefining treatment possibilities for retinal diseases worldwide. Every role here contributes to improving vision and transforming patient outcomes across the globe.